Literature DB >> 327148

[Concentration of C-peptide in correlation to kidney function (author's transl)].

T Zilker, H Wiesinger, R Ermler, U Schweigart, P Bottermann.   

Abstract

Recently, the radioimmunological determination of C-peptide came into interest because of the jugdement of the remaining function of the islet apparatus in insulin-dependent diabetics. As the degradation of C-peptide preferably takes place in the kidney we performed an intravenous glucose load in 32 patients with kidney diseases. The following results were obtained: 1. In patients with a healthy carbohydrate metabolism a clear correlation exists between the concentration of creatinine on the one hand, the creatinine-clearance and the fasting C-peptide concentration respectively the measured amount of C-peptide on the other hand. 2. The more advanced the renal insufficiency the better is the correlation between the parameter of the kidney function and the C-peptide concentration. 3. In diabetic patients there shows to be no clear correlation between the C-peptide levels and the kidney function. --In insulin-dependent diabetics the amount of C-peptide is only of diagnostic use if the renal function is well known.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 327148     DOI: 10.1007/bf01489004

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  11 in total

1.  [ON EARLY DETECTION OF LATENT DIABETIC METABOLIC CONDITIONS. INTRAVENOUS GLUCOSE TOLERANCE TEST AS A CLINICAL ROUTINE TEST].

Authors:  P C SCRIBA; K SCHWARZ
Journal:  Munch Med Wochenschr       Date:  1964-08-28

2.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

3.  Physiologic significance of the intravenous glucose tolerance test.

Authors:  J R FRANCKSON; H A OOMS; R BELLENS; V CONARD; P A BASTENIE
Journal:  Metabolism       Date:  1962-05       Impact factor: 8.694

4.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

5.  [Specific determination of serum creatinine].

Authors:  E Knoll; D Stamm
Journal:  Z Klin Chem Klin Biochem       Date:  1970-11

6.  [A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl)].

Authors:  D Banauch; W Brümmer; W Ebeling; H Metz; H Rindfrey; H Lang; K Leybold; W Rick; H J Staudinger
Journal:  Z Klin Chem Klin Biochem       Date:  1975-03

7.  Peripheral metabolism of insulin, proinsulin, and C-peptide in the pregnant rat.

Authors:  A I Katz; M D Lindheimer; M E Mako; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

8.  Metabolism of proinsulin, insulin, and C-peptide in the rat.

Authors:  A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

9.  Identification of proinsulin and C-peptide in human serum by a specific immunoassay.

Authors:  F Melani; A H Rubenstein; P E Oyer; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

Review 10.  Proinsulin and the biosynthesis of insulin.

Authors:  D F Steiner; J L Clark; C Nolan; A H Rubenstein; E Margoliash; B Aten; P E Oyer
Journal:  Recent Prog Horm Res       Date:  1969
View more
  2 in total

1.  Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus.

Authors:  H A Chakkera; J K Bodner; R L Heilman; D C Mulligan; A A Moss; K L Mekeel; M J Mazur; K Hamawi; R M Ray; G L Beck; K S Reddy
Journal:  Transplant Proc       Date:  2010-09       Impact factor: 1.066

2.  Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasic; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.